Analysis on survival and prognostic factors in patients with resectable pancreatic adenocarcinoma

被引:0
|
作者
Rong Lin
Chao-qun Han
Wei-jun Wang
Jun Liu
Wei Qian
Zhen Ding
Xiao-hua Hou
机构
[1] Huazhong University of Science and Technology,Department of Gastroenterology, Union Hospital, Tongji Medical College
关键词
pancreatic adenocarcinoma; survival; prognosis; lymph node ratio;
D O I
暂无
中图分类号
学科分类号
摘要
Survival after pancreatic cancer surgery is extremely unfavorable even after curative resection. Prognostic factors have been explored but remain largely undefined. The present study was to identify the role of clinical and laboratory variables in the prognostic significance of resectable pancreatic adenocarcinoma. A total of 96 patients who underwent curative resection for pancreatic cancer were included. Survival was evaluated based on complete follow-up visits and was associated with potential prognostic factors using the Kaplan-Meier method and Cox proportional hazard model survival analyses. The results showed that prognostic variables significantly reduced survival, including old age, poorly differentiated tumors, elevated tumor markers and positive lymph node metastasis (LNM). Age of older than 60 years (HR=1.83, P=0.04), LNM (HR=2.22, P=0.01), lymph node ratio (0<LNR≤0.2, HR=1.38, P=0.042; LNR>0.2, HR=1.92, P=0.017), initial CA199 (HR=4.80, P=0.004), and CEA level (HR=2.59, P=0.019) were identified as independent prognostic factors by multivariate analysis. It was concluded that LNR may be potent predictor of survival and suggests that surgeons and the pathologists should thoroughly assess lymph nodes prior to surgery.
引用
收藏
页码:612 / 620
页数:8
相关论文
共 50 条
  • [31] Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma
    Gruber, Elisabeth S.
    Jomrich, Gerd
    Tamandl, Dietmar
    Gnant, Michael
    Schindl, Martin
    Sahora, Klaus
    PLOS ONE, 2019, 14 (05):
  • [32] Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
    Kim, Seung-seob
    Lee, Sunyoung
    Lee, Hee Seung
    Bang, Seungmin
    Park, Mi-Suk
    ABDOMINAL RADIOLOGY, 2021, 46 (02) : 655 - 666
  • [33] Prognostic factors in patients with locally advanced or borderline resectable pancreatic ductal adenocarcinoma: chemotherapy vs. chemoradiotherapy
    Seung-seob Kim
    Sunyoung Lee
    Hee Seung Lee
    Seungmin Bang
    Mi-Suk Park
    Abdominal Radiology, 2021, 46 : 655 - 666
  • [34] Prognostic factors associated with survival and recurrence in resectable gastroesophageal adenocarcinoma: retrospective analysis of 497 patients operated at two Italian centers.
    Ghidini, Michele
    Botticelli, Andrea
    Donida, Bianca Maria
    Strigari, Lidia
    Onesti, Concetta Elisa
    Ratti, Margherita
    Pizzo, Claudio
    Aldighieri, Federico
    Toppo, Laura
    Ranieri, Valerio
    Occhipinti, Mario
    Senti, Chiara
    Tanzi, Giulia
    Mazzuca, Federica
    Marchetti, Paolo
    Martinotti, Mario
    Passalacqua, Rodolfo
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [35] Modeling Prognostic Factors in Resectable Pancreatic Adenocarcinomas
    Botsis, Taxiarchis
    Anagnostou, Valsamo K.
    Hartvigsen, Gunnar
    Hripcsak, George
    Weng, Chunhua
    CANCER INFORMATICS, 2009, 7 : 281 - 291
  • [36] Prognostic Factors for Survival in Patients Undergoing Curative Resection After Neoadjuvant FOLFIRINOX in Borderline Resectable Pancreatic Cancer
    Barenboim, A.
    Lahat, G.
    Nachmany, I.
    Brazowsk, E.
    Geva, R.
    Wolf, I.
    Golan, T.
    Klausner, J.
    Lubezky, N.
    ANNALS OF SURGICAL ONCOLOGY, 2020, 27 (SUPPL 1) : S135 - S135
  • [37] Prognostic Factors for Survival of Colorectal Adenocarcinoma Patients in Uganda
    Wismayer, Richard
    Kiwanuka, Julius
    Wabinga, Henry
    Odida, Michael
    CANCER MANAGEMENT AND RESEARCH, 2022, 14 : 875 - 893
  • [38] Prognostic factors for survival in patients with metastatic lung adenocarcinoma: Analysis of the SEER database
    Campos Balea, B.
    de Castro Carpeno, J.
    Massuti, B.
    Vicente-Baz, D.
    Perez Parente, D.
    Ruiz Gracia, P.
    Cobo Dols, M.
    ANNALS OF ONCOLOGY, 2020, 31 : S880 - S880
  • [39] Prognostic factors for survival in patients with metastatic lung adenocarcinoma: An analysis of the SEER database
    Campos-Balea, Begona
    de Castro Carpeno, Javier
    Massuti, Bartomeu
    Vicente-Baz, David
    Perez Parente, Diego
    Ruiz-Gracia, Pedro
    Crama, Leonardo
    Cobo Dols, Manuel
    THORACIC CANCER, 2020, 11 (11) : 3357 - 3364
  • [40] Prognostic factors for achieving resection following neoadjuvant radiation therapy for borderline resectable pancreatic adenocarcinoma
    Dholakia, Avani Satish
    Hacker-Prietz, Amy
    Wild, Aaron Tyler
    Raman, Siva P.
    Wood, Laura D.
    Laheru, Daniel A.
    Zheng, Lei
    De Jesus-Acosta, Ana
    Dung Thi Le
    Rasheed, Zeshaan
    Ellsworth, Susannah G.
    Kumar, Rachit
    Fan, Katherine Y.
    Pawlik, Timothy M.
    Makary, Martin
    Hruban, Ralph H.
    Cameron, John L.
    Fishman, Elliott K.
    Wolfgang, Christopher Lee
    Herman, Joseph M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)